Metabolic Fate of 1-Hexylcarbamoyl-5-fluorouracil in Rats
- 1 January 1978
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 8 (9) , 547-556
- https://doi.org/10.3109/00498257809061254
Abstract
1. The metabolic fate of a new antitumour agent, 1-hexylcarbamoyl-5-fluoro[6-14C]uracil (14C-HCFU) in rats after oral administration was compared with that of 5-fluoro[6-14C]uracil (14C-FU). 2. Tissue radioactivity reached a max. 1 to 3 h after administration of 14C-HCFU and 0.5 h after 14C-FU. 3. Both drugs were excreted rapidly, mostly in urine. Expired 14CO2 from 14C-HCFU was significantly less than that from 14C-FU. 4. Unchanged FU was not detected in plasma 3 h after administration of 14C-FU, whereas FU was detected in plasma 5 h after 14C-HCFU. The pyrimidine ring of 14C-HCFU might be degradated more slowly than that of 14C-FU. 5. 1-(5-Carboxypentylcarbamoyl)-5-fluorouracil and 1-(3-carboxypropylcar-bamoyl)-5-fluorouracil were identified as the major urinary metabolites of 14C-HCFU.This publication has 17 references indexed in Scilit:
- 5-Fluorouracil Derivatives. I. The Synthesis of 1-Carbamoyl-5-fluorouracilsBulletin of the Chemical Society of Japan, 1977
- Studies on the Metabolic Fate of 5-Fluorouracil in the Oral AdministrationYAKUGAKU ZASSHI, 1974
- The Study on Metabolic Fate of 5-Fluorouracil-6-14C after Percutaneous AdministrationYAKUGAKU ZASSHI, 1973
- Synthese und einige Reaktionen des 2-Fluor-3-hydroxypropionsäure-äthylestersCollection of Czechoslovak Chemical Communications, 1964
- Studies on Fluorinated PyrimidinesPublished by Elsevier ,1960
- Studies on fluorinated pyrimidines: VII—the degradative pathwayBiochemical Pharmacology, 1959
- AN ANTIMALARIAL ALKALOID FROM HYDRANGEA. VI. A SECOND SYNTHESIS OF 3-[β-KETO-γ-(2-PIPERIDYL)-PROPYL]-4-QUINAZOLONEThe Journal of Organic Chemistry, 1952
- Electrolytically Induced ReactionsScience, 1949